172152-19-1

Basic information

• Product Name: D2PM (hydrochloride)
• Synonyms: D2PM (hydrochloride);(2R)-α,α-Diphenyl-2-pyrrolidineMethanol Hydrochloride;(R)-D2PM Hydrochloride;(R)-α,α-Diphenyl-2-pyrrolidineMethanol Hydrochloride;(R)-α,α-Diphenylprolinol Hydrochloride;α,α-Diphenyl-D-prolinol Hydrochloride
• CAS NO: 172152-19-1
• Molecular Formula: C17H20ClNO
• Molecular Weight: 289.7998
• Product Categories: Aromatics, Heterocycles, Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 172152-19-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: D2PM (hydrochloride)(CAS DataBase Reference)
• NIST Chemistry Reference: D2PM (hydrochloride)(172152-19-1)
• EPA Substance Registry System: D2PM (hydrochloride)(172152-19-1)

Safety Data

• Hazardous Substances Data: 172152-19-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
D2PM (hydrochloride) is used as a pharmaceutical agent for its norepinephrine-dopamine reuptake inhibitory properties. It is particularly valuable in the treatment of neurological and psychiatric disorders due to its ability to modulate neurotransmitter levels in the brain, leading to improved symptoms and overall well-being.
Used in Research and Development:
In the field of research and development, D2PM (hydrochloride) serves as a valuable compound for studying the mechanisms of neurotransmitter reuptake and the development of novel therapeutic agents. Its enantiomeric selectivity and pharmacological activity make it an important tool in understanding the role of specific neurotransmitters in various conditions and the potential for targeted drug development.
Used in Drug Delivery Systems:
Similar to gallotannin, D2PM (hydrochloride) can also benefit from novel drug delivery systems to enhance its applications and efficacy. These systems can improve the delivery, bioavailability, and therapeutic outcomes of D2PM (hydrochloride) by employing various organic and metallic nanoparticles as carriers, targeting specific areas of the body and reducing potential side effects.